Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07283939 · ClinicalTrials.gov registry record · NA
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
A NA study, sponsored by Alliance for Clinical Trials in Oncology.
- Recruiting
- Registry status
- NA
- Development phase
- 420
- Enrollment target
NCT07283939 is a NA study that is actively recruiting participants, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 420 participants.
The verdict
NCT07283939, a NA study, is actively recruiting participants, sponsored by Alliance for Clinical Trials in Oncology.
- RECRUITING
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
Study Summary
This study seeks to learn whether using the PAGODA algorithm to guide chemotherapy dosing will lower the chance of unplanned delays during chemotherapy for cancer in the gastrointestinal system compared to usual care.
Interventions
- DRUG Fluorouracil
- DRUG Oxaliplatin
- DRUG Folinic Acid
- OTHER PAGODA algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2026-02-13 |
| Est. Completion | 2030-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07283939
The ClinicalTrials.gov registry entry for NCT07283939 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Fluorouracil is the first listed.
NCT07283939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07283939 about?
NCT07283939 is a clinical study titled "Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays". This study seeks to learn whether using the PAGODA algorithm to guide chemotherapy dosing will lower the chance of unplanned delays during chemotherapy for cancer in the gastrointestinal system compared to usual care.
What is the current status of trial NCT07283939?
This trial is currently recruiting. It is a NA study. The enrollment target is 420 participants. The study started on 2026-02-13. Estimated completion is 2030-05-02.
What interventions are being tested in trial NCT07283939?
The interventions under investigation include: Fluorouracil (DRUG), Oxaliplatin (DRUG), Folinic Acid (DRUG), PAGODA algorithm (OTHER).
Who is sponsoring clinical trial NCT07283939?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.